Hutch News

Hutch News

Stories tagged 'stem cell'

Appelbaum editorial: Evidence tips transplant practice back to bone marrow

In New England Journal of Medicine editorial, Fred Hutchinson Cancer Research Center’s Dr. Fred Appelbaum argues adult stem cells harvested from bone marrow rather than blood of unrelated donors are best for reducing graft-vs.-host disease risk

Oct. 22, 2012 | By Dean Forbes

View story >


Watts' cord blood research garners award

Kiem Lab's Korashon Watts explores cord blood stem cell expansion; lauded by American Society of Gene & Cell Therapy

May 21, 2012 | By Colleen Steelquist

Dr. Korashon Watts of the Fred Hutchinson Cancer Research Center Clinical Research Division recently won an Excellence in Research award from the American Society of Gene & Cell Therapy. Her abstract, focused on cord blood stem cell expansion, was selected as one of the top six submitted by a postdoctoral fellow or student for the ASGCT annual meeting in Philadelphia earlier this month.

View story >


Bradley, Skene win Damon Runyon awards

Robert Bradley's $100,000 continuation award supports alternative RNA splicing research; Peter Skene's $156,000 grant aids cellular reprogramming efforts

Jan. 17, 2012

Two Fred Hutchinson Cancer Research Center researchers have received prestigious awards from the Damon Runyon Cancer Research Foundation.

View story >


Modified marrow cells may resist chemotherapy’s toxic effects

Hans-Peter Kiem and colleagues find chemo-resistant genes may enable safer, more effective treatment for brain cancer patients

May 23, 2011 | By Dean Forbes

Chemotherapy kills cancer cells, but its toxic effects on normal cells such as bone marrow and blood cells limits its use. Fred Hutchinson Cancer Research Center researchers have found a possible approach to reduce this toxicity: modify the bone marrow cells with a gene that makes them resistant to chemotherapy.

View story >


Mouse mammary stem cell discovery

Identification, isolation of adult cells may lead to breast tissue regeneration, new cancer drug targets

Sept. 7, 2010 | By Kristen Woodward

Researchers at the Fred Hutchinson Cancer Research Center are the first to identify and isolate adult mammary stem cells in mice. Long-term implications of this research may include the use of such cells to regenerate breast tissue, provide a better understanding of the role of adult stem cells in breast cancer development, and develop potential new targets for anti-cancer drugs.

View story >


Paddison funded for brain cancer research

Award targets need for glioblastoma therapies, disease model

Aug. 30, 2010 | By Colleen Steelquist

Dr. Patrick Paddison of the Human Biology Division of the Fred Hutchinson Cancer Research Center was recently awarded $148,000 by Accelerate Brain Cancer Cure to identify and develop combination therapies for glioblastoma, the most common and most aggressive form of brain cancer in adults.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.